{"schema_version":"1","generated_at":"2026-11-06T18:06:20.230Z","data_as_of":null,"url":"https://www.findmykol.com/kol/bipinkumar-amin","json_url":"https://www.findmykol.com/kol/bipinkumar-amin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"bipinkumar-amin","name":"Bipinkumar Amin","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Merck & Co.","institution_url":"https://www.findmykol.com/institution/merck-co","city":"Watertown","state":"SD","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1568415628","openalex":"A5051037678"},"summary":"Bipinkumar Amin is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 7 publications with 651 citations (h-index 7).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":7,"cited_by_count":651,"h_index":7,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":72,"program_years":{"first":2021,"last":null},"rows_total":178,"shown":3,"withheld":175,"rows":[{"payer":"BeOne Medicines","program_year":2025,"amount_usd":227385.16,"payment_count":14,"source_url":"https://openpaymentsdata.cms.gov/search?query=1568415628"},{"payer":"BeiGene","program_year":2025,"amount_usd":118502.1,"payment_count":12,"source_url":"https://openpaymentsdata.cms.gov/search?query=1568415628"},{"payer":"Geron Corporation","program_year":2025,"amount_usd":12767.14,"payment_count":14,"source_url":"https://openpaymentsdata.cms.gov/search?query=1568415628"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1568415628","source":"payments"},"publications":{"total":7,"shown":5,"withheld":2,"matched_by":"OpenAlex author record","recent":[{"title":"Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial","year":2019,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(19)30152-4","status":"verified"},{"title":"Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial","year":2019,"journal":"The Lancet Infectious Diseases","source_url":"https://doi.org/10.1016/s1473-3099(19)30310-x","status":"verified"},{"title":"A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia.","year":2014,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7123","status":"verified"},{"title":"Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study","year":2011,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2010.32.1844","status":"verified"},{"title":"Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study.","year":2009,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.v114.22.933.933","status":"verified"}],"source":"works"},"contact":{"address_1":"401 9TH AVE NW","city":"Watertown","state":"SD","zip":"572011548","phone":"605-882-6800","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1568415628","source":"identity"},"similar":[{"name":"Ednan Bajwa","slug":"ednan-bajwa","institution":"Merck & Co.","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ednan-bajwa","json_url":"https://www.findmykol.com/kol/ednan-bajwa/profile.json"},{"name":"Annaswamy Raji","slug":"annaswamy-raji","institution":"Merck & Co.","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/annaswamy-raji","json_url":"https://www.findmykol.com/kol/annaswamy-raji/profile.json"},{"name":"Ritu Valiyil","slug":"ritu-valiyil","institution":"Merck & Co.","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/ritu-valiyil","json_url":"https://www.findmykol.com/kol/ritu-valiyil/profile.json"},{"name":"Vassiliki Karantza-Wadsworth","slug":"vassiliki-karantza-wadsworth","institution":"Merck & Co.","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/vassiliki-karantza-wadsworth","json_url":"https://www.findmykol.com/kol/vassiliki-karantza-wadsworth/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":175,"publications":2}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-06-21","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}